November 12, 2012 15:08
FAS green-lights AFK Sistema bid to buy 100% of VeroPharm, but with terms (Part 2)
MOSCOW. Nov 12 (Interfax) - Russia's Federal Antimonopoly Service (FAS) has approved AFK Sistema's (RTS: AFKS) request for permission to buy 100% of the stock in pharmaceuticals company OJSC VeroPharm (RTS: VRPH), but has attached some terms, a FAS statement says.
The FAS established that VeroPharm has a dominating position on the market for medicines with MNN Gemifloksatsin, and its subsidiary LLC LENS-Pharm with MNN Poliadenilovaya Kislota + Poliuridilovaya Kislota.
The FAS takes the view that the conduct of this deal could lead to a limiting of access to the market for the sale of these medical preparations by independent counteragent VeroPharm and LENS-Pharm. In light of this, the FAS requires of Sistema and VeroPharm to ensure the fulfillment of all contracts for the delivery of all medicines existing on the date the deal is completed.
Before the deal is done, Sistema is to post on its official website the document regulating its commercial policy as regards VeroPharm medical preparations, and announce changes to commercial policy in letter form to the FAS within thirty days.
The parties are not to, from the date the deal is completed, effect any unfounded economic or technological reduction or halt of the production and supply of goods that are still in demand. They are also to announce to the FAS either of such circumstances in letter form within thirty days.
AFK Sistema and VeroPharm are to annually inform the FAS in letter form that they are meeting these conditions.
The parties to the deal are to announce its completion to the anti-monopoly agency within twenty days from the day the deal is wrapped up.
According to DSM Group data, VeroPharm is third in a rating of the largest Russian pharmaceutical companies. Company product is provided by three plants: in Belgorod, Voronezh, and Pokrov. VeroPharm specializes in the production of Rx medical goods, which account for about 70% of its sales revenues.
Pharmacy Chain 36.6 (RTS: APTK) owns 51.8% of the company.
(Our editorial staff can be reached at email@example.com)
August 24, 2017
Russia calls on N.Korea to abstain from military response to U.S.-South Korean drills
Russia plans to deliver 24 Su-35 fighter jets to UAE - FSMTC
Russia to deliver large batch of armored vehicles to Iraq - FSMTC head
RUSSIAN FOREIGN MINISTRY: DEPLOYMENT OF U.S. MISSILE DEFENSE SYSTEMS IN JAPAN TO UNDERMINE STABILITY IN NORTHERN PART OF ASIA PACIFIC REGION
RUSSIA PLANS TO DELIVER 24 SUKHOI SU-35 FIGHTER JETS TO UNITED ARAB EMIRATES - FSMTC
RUSSIA TO SUPPLY LARGE BATCH OF ARMORED VEHICLES TO IRAQ - FSMTC HEAD TO INTERFAX
RUSSIAN FOREIGN MINISTRY: LAUNCHED U.S.-S. KOREA DRILLS NOT AIDING DE-ESCALATION OF SITUATION ON KOREAN PENINSULA
RUSSIAN FOREIGN MINISTRY URGES NORTH KOREA TO SHOW RESTRAINT, NOT TO GIVE MILITARY RESPONSE TO DRILLS HELD BY SEOUL, WASHINGTON
RUSSIAN FOREIGN MINISTRY: WASHINGTON'S STATEMENTS OF MOSCOW ALLEGEDLY SUPPLYING ARMS TO TALIBAN IN AFGHANISTAN DON'T FACILITATE EFFICIENT RUSSIA-U.S. INTERACTION
Lavrov to leave for Qatar, Kuwait, UAE on Aug 27 to discuss Syria, Gulf crisis
RUSSIAN FOREIGN MINISTRY: TRUMP'S NEW STRATEGY'S FOCUS ON MILITARY SOLUTION FOR AFGHANISTAN WON'T LEAD TO POSITIVE RESULT
MICEX and RTS Indexes at 11:00 MSK
MOSCOW DENIES U.S. ACCUSATIONS OF RUSSIAN ARMS DELIVERY TO TALIBAN - RUSSIAN FOREIGN MINISTRY
Russian ambassador to Sudan died of heart attack - Russian Foreign Ministry